Not applicableNot Yet RecruitingNCT04167332What this trial is testingProspective Collection of Samples for Urothelial Cancer of BladderWho this might be right forBladder Cancer Universitaire Ziekenhuizen KU Leuven 630
Early research (Phase 1)Looking for participantsNCT05521698What this trial is testingTrial of Bicalutamide in Non-Muscle Invasive Bladder CancerWho this might be right forNon-Muscle Invasive Bladder Urothelial CarcinomaRecurrent Non-Muscle Invasive Bladder Urothelial Carcinoma University of Wisconsin, Madison 80
Early research (Phase 1)Study completedNCT03854721What this trial is testingIntravesical VAX014 for Instillation in Subjects With Non-Muscle Invasive Bladder CancerWho this might be right forUrothelial Carcinoma of the Urinary Bladder Vaxiion Therapeutics 6
Not applicableNot Yet RecruitingNCT06727214What this trial is testingSurvival Benefits of Neoadjuvant Systemic Chemotherapy in Muscle Invasive Bladder CancerWho this might be right forBladder Urothelial Carcinoma Sara Mahmoud Ahmed Mahmoud 87
Testing effectiveness (Phase 2)UnknownNCT05328336What this trial is testingPerioperative Tislelizumab Combined With Nab-Paclitaxel for Muscle-invasive Urothelial Bladder Cancer: A Multicenter StudyWho this might be right forMuscle Invasive Bladder Cancer Urothelial Carcinoma Tianjin Medical University Second Hospital 74
Not applicableLooking for participantsNCT07302230What this trial is testingHome-Based Physical Activity Program With Digital App Versus Health Education Group for Improving Physical Activity Among Patients With Non-muscle Invasive Bladder Cancer, The EMPOWER TrialWho this might be right forLocalized Non-Muscle Invasive Bladder Urothelial CarcinomaStage 0a Bladder Cancer AJCC v8Stage 0is Bladder Cancer AJCC v8+1 more University of Washington 100
Very early researchActive Not RecruitingNCT07821177What this trial is testingBladder Preservation or Cystectomy for MIBCWho this might be right forMuscle-Invasive Bladder CarcinomaBladder CancerUrothelial Carcinoma Dana-Farber Cancer Institute 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT02621151What this trial is testingPembrolizumab (MK3475), Gemcitabine, and Concurrent Hypofractionated Radiation Therapy for Muscle-Invasive Urothelial Cancer of the BladderWho this might be right forMuscle-invasive Urothelial Cancer of the Bladder NYU Langone Health 60